Over 700 Total Lots Up For Auction at Three Locations - NC 02/01, NY 02/02, UT 02/03

Danish university installs MILabs PET/SPECT/CT system

by John R. Fischer, Senior Reporter | February 12, 2018
CT Molecular Imaging PET SPECT X-Ray
The University of Copenhagen
has installed a MILabs PET-SPECT-CT
system to research neurological disorders
Researchers at the University of Copenhagen can now investigate neuronal disorders on the basis of glial cell biology thanks to the installation of MILabs’ PET/SPECT/CT system.

The VECTor5CT multimodality solution is equipped with molecular, functional and anatomical tomographic imaging capabilities, and will be run out of the Center for Translational Neuroscience in the laboratory of professor Maiken Nedergaard, discoverer of the glymphatic system, which is the brain equivalent of the lymphatic system.

“This new instrument will facilitate our research of cerebral blood flow and its glial regulation, so that disorders long thought neuronal in nature can now be investigated as disorders principally of glial cells, including both astrocytes and oligodendrocytes, as well as their progenitors,” said Nedergaard in a statement.

Your Centrifuge Specialty Store

Quality remanufactured Certified Centrifuges at Great prices! Fully warranted and backed by a company you can trust! Call or click for a free quote today! www.Centrifugestore.com 800-457-7576

Capabilities of the system include sub-mm PET, 0.14 mm Exirad-SPECT, quarter mm in-vivo SPECT, X-ray CT imaging with 4µm voxel-resolutions and ultra low-dose and ultra-fast imaging.

MILABS recently installed another of its solutions, a scalable U-CTUHR microCT system at the University of Pennsylvania’s department of radiology this past July, as well as its VECTor5OI/CT at the Erasmus MC and Medical Delta in the Netherlands in September.

“We are extremely pleased to provide enabling ultra-high resolution Exirad-3D and VECTor/CT molecular and functional research tools that allow the Glial Disease and Therapeutics lab to explore the development of new CNS diagnostic and therapeutic methods based on glial biology,” Prof. Frederik Beekman, CEO of MILabs B.V., said in a statement.

The University of Copenhagen did not respond for comment.

You Must Be Logged In To Post A Comment